Bladder Cancer SNP Panel Predicts Susceptibility And Survival

Main Category: Urology / Nephrology
Also Included In: Cancer / Oncology
Article Date: 30 Mar 2009 - 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (2 votes)

Healthcare Prof:not yet rated


UroToday.com - Bladder cancer is a common GU tumor that has clear genetic basis regarding formation and progression. Chromosomal abnormalities on 5, 7, and 9 have been associated with tumor formation and or progression. These authors evaluated the role of single nucleotide polymorphisms (SNPs) and bladder cancer risk and case survival. The authors used a panel of SNPs in potential cancer regulatory pathways, including cell cycle, cell growth, detoxification, telomerase, and apoptosis. They ranked causative or survival-associated single gene and multi-gene-combinations using a large, population-based case-control study in New Hampshire, USA.

There were 832 cancer patients and 1,191 controls. The vast majority had non-invasive bladder cancer. 1,421 SNPs were evaluated, representing 400 cancer related genes. Bladder cancer risk was associated with altered genes in detoxification (GSTZ1_02 and pG42R), PAH metabolism (AKR1C3_35), pigmentation (TYR_02), lipid metabolism (SCARB1_03), and metabolism (SLC23A1_05). Altered genes associated with bladder cancer survival included surface antigens (CD80_04), apoptosis (BCL2L1_03 and CASP9), detoxification (EPHX1_15), and DNA repair (ERCC4_01).

The occurrence and prognosis for bladder cancer is most likely controlled by a combination of multiple genetic factors and exposures, rather than a single polymorphism. However, this well done study has identified genetic alterations that can be assessed in population-based studies to identify individuals at higher risk for the formation and progression of bladder cancer.

Andrew AS, Gui J, Sanderson AC, Mason RA, Morlock EV, Schned AR, Kelsey KT, Marsit CJ, Moore JH, Karagas MR
Hum Genet. 2009 Mar 1. Epub ahead of print.
doi:10.1007/s00439-009-0645-6

Written by UroToday.com Contributing Editor David P. Wood, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2009 - UroToday

Article adapted by Medical News Today from original press release.
Visit our urology / nephrology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urotoday. "Bladder Cancer SNP Panel Predicts Susceptibility And Survival." Medical News Today. MediLexicon, Intl., 30 Mar. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/144174.php>

APA
Urotoday. (2009, March 30). "Bladder Cancer SNP Panel Predicts Susceptibility And Survival." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/144174.php.

Please note: If no author information is provided, the source is cited instead.


Urology / Nephrology

Most Popular Articles



Follow Our Urology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Urology / Nephrology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »